Nanoscale Mapping of EGFR and c-MET Protein Environments on Lung Cancer Cell Surfaces via Therapeutic Antibody Photocatalyst Conjugates | ACS Chemical Biology
Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study - The Lancet Digital Health
Gene Mutations in Lung Cancer: Promising Predictive Factors for the Success of Molecular Therapy | PLOS Medicine
Personalized medicine and inhibition of EGFR signaling in lung cancer. | Semantic Scholar
Molecular Markers and Targeted Therapies in the Management of Non-Small Cell Lung Cancer | MDedge Hematology and Oncology
Classifying EGFR mutations by structure and function offers better way to match non-small cell lung cancer patients to treatments | MD Anderson Cancer Center
Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop - ScienceDirect
EGFR | Cancer Genetics Web
Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes | Nature Communications
Cancer Cytopathology on Twitter: "Data reveals cell-free DNA can be extracted from lung cancer FNA supernatants for EGFR mutation analysis, an important marker for targeted therapy in patients with advanced lung cancer.
EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancer
Multiplicity of EGFR and KRAS Mutations in Non-small Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors | Anticancer Research
IJMS | Free Full-Text | Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors | Science Translational Medicine
Overcoming therapy resistance in EGFR-mutant lung cancer | Nature Cancer
Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity - ScienceDirect
Frontiers | Rethink of EGFR in Cancer With Its Kinase Independent Function on Board
Cancers | Free Full-Text | Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies
Cells | Free Full-Text | Emerging Molecular Dependencies of Mutant EGFR-Driven Non-Small Cell Lung Cancer
A favourable prognostic marker for EGFR mutant non-small cell lung cancer: immunohistochemical analysis of MUC5B | BMJ Open
EGFR and Lung Cancer | American Lung Association
Frontiers | Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies
Frontiers | EGFR-Dependent Extracellular Matrix Protein Interactions Might Light a Candle in Cell Behavior of Non-Small Cell Lung Cancer
EGFR and Lung Cancer | American Lung Association
